Compare $CAPR vs $OVID | Chartloom

Compare

$CAPR vs $OVID

Capricor Therapeutics Inc · Ovid Therapeutics Inc

CAPR

Capricor Therapeutics Inc

OVID

Ovid Therapeutics Inc

Compare $CAPR vs $OVID

Comparing Capricor Therapeutics Inc and Ovid Therapeutics Inc

CAPRCapricor Therapeutics Inc

OVIDOvid Therapeutics Inc

CAPRCapricor Therapeutics Inc

Market cap

$453M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.84x

Rev growth (TTM)

-100.0%

YTD performance

-72.3%

52W performance

4.4%

FCF yield

-28.6%

OVIDOvid Therapeutics Inc

Market cap

$459M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1,284.26x

Rev growth (TTM)

-76.2%

YTD performance

39.8%

52W performance

55.7%

FCF yield

-11.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAPR

OVID

Detailed metrics comparison

CAPR

Capricor Therapeutics Inc

OVID

Ovid Therapeutics Inc

Market Cap

CAPR$453M

OVID$459M

Enterprise Value

CAPR$433M

OVID$448M

Price

CAPR$7.83

OVID$2.46

P/E Ratio

CAPRN/A

OVIDN/A

P/S Ratio

CAPR23.36x

OVID290.04x

EV/Sales

CAPR22.42x

OVID282.89x

EV/EBITDA

CAPR1,019.20x

OVID3.65x

P/B Ratio

CAPR2.11x

OVID2.21x

P/FCF Ratio

CAPRN/A

OVIDN/A

EV/FCF

CAPR-3.33x

OVID-8.18x

PEG Ratio

CAPRN/A

OVIDN/A

Forward P/E (NTM)

CAPRN/A

OVIDN/A

Forward P/S (NTM)

CAPR6.84x

OVID1,284.26x

Revenue (TTM)

CAPR$0

OVID$2M

Revenue Growth (YoY)

CAPR-100.0%

OVID-76.2%

Forward Rev Growth

CAPR-27.8%

OVID-72.6%

Gross Margin (TTM)

CAPR0.0%

OVID0.0%

Operating Margin (TTM)

CAPR0.0%

OVID0.0%

EBITDA Margin (TTM)

CAPR0.0%

OVID-3681.4%

Net Margin (TTM)

CAPR0.0%

OVID-2178.9%

FCF Margin (TTM)

CAPRN/A

OVID-3460.1%

Net Income (TTM)

CAPR$-129M

OVID$-34M

FCF (TTM)

CAPR$-130M

OVID$-55M

EPS (TTM)

CAPR-$2.23

OVID-$0.17

ROE (TTM)

CAPR-5660.0%

OVID-2364.0%

ROA (TTM)

CAPR-4397.0%

OVID-2052.0%

ROIC (TTM)

CAPR-5562.0%

OVID-2364.0%

Cash

CAPR$21M

OVID$11M

Debt

CAPR$0

OVID$0

Net Cash/Debt

CAPR$21M

OVID$11M

Current Ratio (TTM)

CAPR7.35x

OVID12.39x

Quick Ratio (TTM)

CAPR7.22x

OVID11.75x

Debt/Equity (TTM)

CAPR0.02x

OVID0.00x

Debt/Assets (TTM)

CAPR0.0%

OVID0.0%

Interest Coverage (TTM)

CAPRN/A

OVIDN/A

Net Debt/EBITDA (TTM)

CAPR0.00x

OVID0.00x

Beta

CAPR0.59

OVID0.28

52W Performance

CAPR4.4%

OVID55.7%

YTD Performance

CAPR-72.3%

OVID39.8%

% from 52W High

CAPR-80.6%

OVID-20.8%

% from 52W Low

CAPR164.5%

OVID108.5%

Asset Turnover (TTM)

CAPR0.25x

OVID0.01x

FCF Yield (TTM)

CAPR-28.6%

OVID-11.9%

Earnings Yield (TTM)

CAPR-28.5%

OVID-7.5%

Dividend Yield (TTM)

CAPRN/A

OVIDN/A

Rule of 40

CAPR-100.0

OVID-3,536.3

EV/GP/RG

CAPRN/A

OVIDN/A

Ticker research

View CAPR research View OVID research

Metric	CAPR Capricor Therapeutics Inc	OVID Ovid Therapeutics Inc
Market & Valuation
Market Cap	$453M	$459M
Enterprise Value	$433M	$448M
Price	$7.83	$2.46
P/E Ratio	N/A	N/A
P/S Ratio	23.36x	290.04x
EV/Sales	22.42x	282.89x
EV/EBITDA	1,019.20x	3.65x
P/B Ratio	2.11x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.33x	-8.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.84x	1,284.26x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	-100.0%	-76.2%
Forward Rev Growth	-27.8%	-72.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3681.4%
Net Margin (TTM)	0.0%	-2178.9%
FCF Margin (TTM)	N/A	-3460.1%
Net Income (TTM)	$-129M	$-34M
FCF (TTM)	$-130M	$-55M
EPS (TTM)	-$2.23	-$0.17
ROE (TTM)	-5660.0%	-2364.0%
ROA (TTM)	-4397.0%	-2052.0%
ROIC (TTM)	-5562.0%	-2364.0%
Financial Health
Cash	$21M	$11M
Debt	$0	$0
Net Cash/Debt	$21M	$11M
Current Ratio (TTM)	7.35x	12.39x
Quick Ratio (TTM)	7.22x	11.75x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	0.28
52W Performance	4.4%	55.7%
YTD Performance	-72.3%	39.8%
% from 52W High	-80.6%	-20.8%
% from 52W Low	164.5%	108.5%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.01x
FCF Yield (TTM)	-28.6%	-11.9%
Earnings Yield (TTM)	-28.5%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-3,536.3
EV/GP/RG	N/A	N/A
Ticker research	View CAPR research	View OVID research

Valuation

P/S Ratio

CAPR

23.36x

OVID

290.04x

EV/FCF

OVID

-8.18x

CAPR

-3.33x

Growth & revenue

Revenue Growth TTM

OVID

-76.2%

CAPR

-100.0%

Forward Revenue Growth

CAPR

-27.8%

OVID

-72.6%

Profitability & performance

Gross Margin

CAPR

0.0%

OVID

0.0%

ROE

OVID

-2364.0%

CAPR

-5660.0%

FCF Yield %

OVID

-11.9%

CAPR

-28.6%

52-Week Performance

OVID

55.7%

CAPR

4.4%

Detailed metrics comparison

CAPR

Capricor Therapeutics Inc

OVID

Ovid Therapeutics Inc

Market Cap

CAPR$453M

OVID$459M

Enterprise Value

CAPR$433M

OVID$448M

Price

CAPR$7.83

OVID$2.46

P/E Ratio

CAPRN/A

OVIDN/A

P/S Ratio

CAPR23.36x

OVID290.04x

EV/Sales

CAPR22.42x

OVID282.89x

EV/EBITDA

CAPR1,019.20x

OVID3.65x

P/B Ratio

CAPR2.11x

OVID2.21x

P/FCF Ratio

CAPRN/A

OVIDN/A

EV/FCF

CAPR-3.33x

OVID-8.18x

PEG Ratio

CAPRN/A

OVIDN/A

Forward P/E (NTM)

CAPRN/A

OVIDN/A

Forward P/S (NTM)

CAPR6.84x

OVID1,284.26x

Revenue (TTM)

CAPR$0

OVID$2M

Revenue Growth (YoY)

CAPR-100.0%

OVID-76.2%

Forward Rev Growth

CAPR-27.8%

OVID-72.6%

Gross Margin (TTM)

CAPR0.0%

OVID0.0%

Operating Margin (TTM)

CAPR0.0%

OVID0.0%

EBITDA Margin (TTM)

CAPR0.0%

OVID-3681.4%

Net Margin (TTM)

CAPR0.0%

OVID-2178.9%

FCF Margin (TTM)

CAPRN/A

OVID-3460.1%

Net Income (TTM)

CAPR$-129M

OVID$-34M

FCF (TTM)

CAPR$-130M

OVID$-55M

EPS (TTM)

CAPR-$2.23

OVID-$0.17

ROE (TTM)

CAPR-5660.0%

OVID-2364.0%

ROA (TTM)

CAPR-4397.0%

OVID-2052.0%

ROIC (TTM)

CAPR-5562.0%

OVID-2364.0%

Cash

CAPR$21M

OVID$11M

Debt

CAPR$0

OVID$0

Net Cash/Debt

CAPR$21M

OVID$11M

Current Ratio (TTM)

CAPR7.35x

OVID12.39x

Quick Ratio (TTM)

CAPR7.22x

OVID11.75x

Debt/Equity (TTM)

CAPR0.02x

OVID0.00x

Debt/Assets (TTM)

CAPR0.0%

OVID0.0%

Interest Coverage (TTM)

CAPRN/A

OVIDN/A

Net Debt/EBITDA (TTM)

CAPR0.00x

OVID0.00x

Beta

CAPR0.59

OVID0.28

52W Performance

CAPR4.4%

OVID55.7%

YTD Performance

CAPR-72.3%

OVID39.8%

% from 52W High

CAPR-80.6%

OVID-20.8%

% from 52W Low

CAPR164.5%

OVID108.5%

Asset Turnover (TTM)

CAPR0.25x

OVID0.01x

FCF Yield (TTM)

CAPR-28.6%

OVID-11.9%

Earnings Yield (TTM)

CAPR-28.5%

OVID-7.5%

Dividend Yield (TTM)

CAPRN/A

OVIDN/A

Rule of 40

CAPR-100.0

OVID-3,536.3

EV/GP/RG

CAPRN/A

OVIDN/A

Ticker research

View CAPR research View OVID research

Metric	CAPR Capricor Therapeutics Inc	OVID Ovid Therapeutics Inc
Market & Valuation
Market Cap	$453M	$459M
Enterprise Value	$433M	$448M
Price	$7.83	$2.46
P/E Ratio	N/A	N/A
P/S Ratio	23.36x	290.04x
EV/Sales	22.42x	282.89x
EV/EBITDA	1,019.20x	3.65x
P/B Ratio	2.11x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.33x	-8.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.84x	1,284.26x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	-100.0%	-76.2%
Forward Rev Growth	-27.8%	-72.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3681.4%
Net Margin (TTM)	0.0%	-2178.9%
FCF Margin (TTM)	N/A	-3460.1%
Net Income (TTM)	$-129M	$-34M
FCF (TTM)	$-130M	$-55M
EPS (TTM)	-$2.23	-$0.17
ROE (TTM)	-5660.0%	-2364.0%
ROA (TTM)	-4397.0%	-2052.0%
ROIC (TTM)	-5562.0%	-2364.0%
Financial Health
Cash	$21M	$11M
Debt	$0	$0
Net Cash/Debt	$21M	$11M
Current Ratio (TTM)	7.35x	12.39x
Quick Ratio (TTM)	7.22x	11.75x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	0.28
52W Performance	4.4%	55.7%
YTD Performance	-72.3%	39.8%
% from 52W High	-80.6%	-20.8%
% from 52W Low	164.5%	108.5%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.01x
FCF Yield (TTM)	-28.6%	-11.9%
Earnings Yield (TTM)	-28.5%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-3,536.3
EV/GP/RG	N/A	N/A
Ticker research	View CAPR research	View OVID research